Form FDA 3455 at a glance
What it is: Form FDA 3455 is the Food and Drug Administration's Disclosure: Financial Interests and Arrangements of Clinical Investigators.
Who signs: The applicant completes this form.
A filled-in Form FDA 3455 example: an applicant discloses an equity interest

How to fill out Form FDA 3455, box by box
Name of clinical investigator and clinical study

Enter the Name of clinical investigator who participated as a clinical investigator in the submitted study.
Enter the Name of clinical study.
The information is submitted in accordance with 21 CFR part 54: the named individual has participated in financial arrangements or holds financial interests that are required to be disclosed.
Applicable check boxes

Mark the applicable check boxes.
Mark any financial arrangement entered into between the sponsor of the covered study and the clinical investigator involved in the conduct of the covered study, whereby the value of the compensation to the clinical investigator for conducting the study could be influenced by the outcome of the study.
Mark any significant payments of other sorts made on or after February 2, 1999, from the sponsor of the covered study, such as a grant to fund ongoing research, compensation in the form of equipment, retainer for ongoing consultation, or honoraria.
Mark any proprietary interest in the product tested in the covered study held by the clinical investigator.
Mark any significant equity interest, as defined in 21 CFR 54.2(b), held by the clinical investigator in the sponsor of the covered study.
Details of the individual's disclosable financial arrangements and interests are attached, along with a description of steps taken to minimize the potential bias of clinical study results by any of the disclosed arrangements or interests.
Sources
[1] Form FDA 3455 (4/26), Disclosure: Financial Interests and Arrangements of Clinical Investigators, Food and Drug Administration (the Official source link on this page).

